AtriCure, Inc. (ATRC)
49.28
+0.30
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
49.27
-0.01
(-0.02%)
After-Hours: 20:00
AtriCure Debt to Equity Ratio : 0.1437 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1437 |
| March 31, 2026 | 0.1524 |
| December 31, 2025 | 0.1555 |
| September 30, 2025 | 0.174 |
| June 30, 2025 | 0.1663 |
| March 31, 2025 | 0.1703 |
| December 31, 2024 | 0.166 |
| September 30, 2024 | 0.1659 |
| June 30, 2024 | 0.163 |
| March 31, 2024 | 0.1652 |
| December 31, 2023 | 0.1598 |
| September 30, 2023 | 0.1607 |
| June 30, 2023 | 0.1618 |
| March 31, 2023 | 0.1654 |
| December 31, 2022 | 0.1559 |
| September 30, 2022 | 0.1661 |
| June 30, 2022 | 0.1641 |
| March 31, 2022 | 0.1627 |
| December 31, 2021 | 0.1564 |
| September 30, 2021 | 0.1436 |
| June 30, 2021 | 0.1936 |
| March 31, 2021 | 0.1582 |
| December 31, 2020 | 0.1633 |
| September 30, 2020 | 0.1786 |
| June 30, 2020 | 0.1795 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3344 |
| December 31, 2019 | 0.309 |
| September 30, 2019 | 0.2959 |
| June 30, 2019 | 0.1998 |
| March 31, 2019 | 0.1983 |
| December 31, 2018 | 0.2104 |
| September 30, 2018 | 0.3203 |
| June 30, 2018 | 0.3286 |
| March 31, 2018 | 0.343 |
| December 31, 2017 | 0.2322 |
| September 30, 2017 | 0.2435 |
| June 30, 2017 | 0.24 |
| March 31, 2017 | 0.2414 |
| December 31, 2016 | 0.2309 |
| September 30, 2016 | 0.2245 |
| June 30, 2016 | 0.22 |
| March 31, 2016 | 0.0776 |
| December 31, 2015 | 0.0758 |
| September 30, 2015 | 0.0005 |
| June 30, 2015 | 0.0005 |
| March 31, 2015 | 0.0006 |
| December 31, 2014 | 0.0009 |
| September 30, 2014 | 0.0192 |
| June 30, 2014 | 0.0008 |
| March 31, 2014 | 0.0008 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp. | 0.5064 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 676.64M |
| Total Liabilities (Quarterly) | 160.21M |
| Shareholders Equity (Quarterly) | 516.43M |
| Current Ratio | 4.218 |
| Net Debt Paydown Yield | 0.04% |